China approves vaccine for children ages 3 to 17 China has approved another vaccine for children ages 3 to 17 as the country works to vaccinate a large portion of its population of 1.4 billon people by the end of this year. Sinovac's COVID-19 vaccine gains China approval for emergency use in children, adolescentsChina has approved emergency use of Sinovac Biotech's (SVA.O) COVID-19 vaccine in people aged between three and 17, its chairman Yin Weidong told state TV late on Friday. WHO approves China’s Sinovac vaccine despite ‘trial data gaps’The UN health agency says there were few older adults enrolled in Sinovac’s clinical trials, so it could not estimate efficacy in people over 60 WHO greenlights China's Sinovac coronavirus vaccineChina's Sinovac coronavirus vaccine "meets international standards for safety, efficacy and manufacturing," the UN health body said on Tuesday. WHO approves China’s Sinovac Covid vaccineEmergency use listing gives countries, funders, procuring agencies and communities assurance it has met international standardsSee all our coronavirus coverage World Health Organization approves China's Sinovac Covid-19 vaccine for emergency useThe World Health Organization (WHO) has approved a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use. The World Health Organization authorizes the Sinovac vaccine for emergency use.The clearance means that the vaccine could be distributed as part of Covax, the global effort to share shots with hard-hit, undersupplied nations. WHO approves Sinovac COVID-19 vaccine for emergency use in second Chinese milestoneThe WHO emergency listing will allow the Sinovac shot to be included in COVAX, the global programme providing vaccines mainly for poor countries.